{
  "id": 1585,
  "text": "4</td></tr><tr><td>Cai et al.77,a</td><td>2006</td><td>52</td><td>Cisplatin/ 5 fluorouracil</td><td>84.6</td><td>5-year: 72.7</td><td>5-year: 84.7</td></tr><tr><td>Behtash et al.543</td><td>2006</td><td>22</td><td>Cisplatin/vincristine</td><td>nr </td><td>nr</td><td>5-year: 28</td></tr><tr><td> Termrungruanglert et al.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 4</td></tr><tr><td>Cai et al.77,a</td><td>2006</td><td>52</td><td>Cisplatin/ 5 fluorouracil</td><td>84.6</td><td>5-year: 72.7</td><td>5-year: 84.7</td></tr><tr><td>Behtash et al.543</td><td>2006</td><td>22</td><td>Cisplatin/vincristine</td><td>nr </td><td>nr</td><td>5-year: 28</td></tr><tr><td> Termrungruanglert et al.\n\n<question>: ",
  "ChatGPT_response_0": "根据研究结果显示，癌症患者的存活率根据不同的治疗方案和疾病阶段可能会有所不同。例如，有一项研究表明使用顺铂/氟尿嘧啶联合化疗的患者5年存活率在72.7%到84.7%之间。另一项研究则显示使用顺铂/长春碱联合化疗的患者5年存活率为28%。因此，癌症患者的存活率取决于多种因素，包括治疗方案、疾病类型和患者个体差异等。如果您想了解特定类型的癌症的存活率，请咨询医生以获取更详细的信息。希望这个回答对您有帮助。",
  "query": "这些研究中癌症患者的存活率是多少？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这些研究中癌症患者的存活率是多少？\n\n<reference text>: 4</td></tr><tr><td>Cai et al.77,a</td><td>2006</td><td>52</td><td>Cisplatin/ 5 fluorouracil</td><td>84.6</td><td>5-year: 72.7</td><td>5-year: 84.7</td></tr><tr><td>Behtash et al.543</td><td>2006</td><td>22</td><td>Cisplatin/vincristine</td><td>nr </td><td>nr</td><td>5-year: 28</td></tr><tr><td> Termrungruanglert et al.\n\n<reply>: ",
  "response": "根据研究结果显示，癌症患者的存活率根据不同的治疗方案和疾病阶段可能会有所不同。例如，有一项研究表明使用顺铂/氟尿嘧啶联合化疗的患者5年存活率在72.7%到84.7%之间。另一项研究则显示使用顺铂/长春碱联合化疗的患者5年存活率为28%。因此，癌症患者的存活率取决于多种因素，包括治疗方案、疾病类型和患者个体差异等。如果您想了解特定类型的癌症的存活率，请咨询医生以获取更详细的信息。希望这个回答对您有帮助。"
}